Literature DB >> 10452335

The endogenous melatonin profile as a marker for circadian phase position.

A J Lewy1, N L Cutler, R L Sack.   

Abstract

Several circadian rhythms have been used to assess the phase of the endogenous circadian pacemaker (ECP). However, when more than one marker rhythm is measured, results do not always agree. Questions then inevitably arise. Are there multiple oscillators? Are some markers more reliable than others? Masking is a problem for all marker rhythms. Masking of melatonin is minimized by sampling under dim light. The dim-light melatonin onset (DLMO) is particularly convenient since it can usually be obtained before sleep. However, assessing the DLMO in low melatonin producers may be problematic, particularly with the commonly used operationally defined threshold of 10 pg/ml. This study evaluates various circadian phase markers provided by the plasma melatonin profile in 14 individuals, several of whom are low melatonin producers. The amount (amplitude) of melatonin production appears to influence the phase of many points on the melatonin profile. Accordingly, when low producers are in a data set, we now prefer a lower DLMO threshold than the one previously recommended (10 pg/ml). Indeed, there are some low producers who never exceed this threshold at any time. Radioimmunoassays are now available that have the requisite sensitivity and specificity to support the use of a lower threshold. Nevertheless, the dim-light melatonin offset (DLMOff), even when operationally defined at thresholds less than 10 pg/ml, appears to be confounded by amplitude in this study; in such cases, it may be preferable to use the melatonin synthesis offset (SynOff) because it is not confounded by amplitude and because, theoretically, it is temporally closer to the endogenous mechanism signaling the offset of production. The question of whether the termination mechanism of melatonin synthesis is related to an interval timer or to a second oscillator loosely coupled to the onset oscillator is probably best answered using the SynOff rather than the DLMOff. It is hoped that these findings will make a useful contribution to the debate on the best ways to use points on the melatonin profile to assess circadian phase position in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452335     DOI: 10.1177/074873099129000641

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  96 in total

1.  Endogenous melatonin profiles in asymptomatic inflammatory bowel disease.

Authors:  Helen J Burgess; Garth R Swanson; Ali Keshavarzian
Journal:  Scand J Gastroenterol       Date:  2010-06       Impact factor: 2.423

Review 2.  Application of long-term microdialysis in circadian rhythm research.

Authors:  Jimo Borjigin; Tiecheng Liu
Journal:  Pharmacol Biochem Behav       Date:  2007-10-25       Impact factor: 3.533

3.  A three pulse phase response curve to three milligrams of melatonin in humans.

Authors:  Helen J Burgess; Victoria L Revell; Charmane I Eastman
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

4.  Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression.

Authors:  Brant P Hasler; Daniel J Buysse; David J Kupfer; Anne Germain
Journal:  Psychiatry Res       Date:  2010-05-14       Impact factor: 3.222

Review 5.  Circadian disruption: What do we actually mean?

Authors:  Céline Vetter
Journal:  Eur J Neurosci       Date:  2018-12-05       Impact factor: 3.386

6.  Combination of light and melatonin time cues for phase advancing the human circadian clock.

Authors:  Tina M Burke; Rachel R Markwald; Evan D Chinoy; Jesse A Snider; Sara C Bessman; Christopher M Jung; Kenneth P Wright
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

7.  Can Circadian Dysregulation Exacerbate Migraines?

Authors:  Jason C Ong; Hannah L Taylor; Margaret Park; Helen J Burgess; Rina S Fox; Sarah Snyder; Jeanetta C Rains; Colin A Espie; James K Wyatt
Journal:  Headache       Date:  2018-05-04       Impact factor: 5.887

Review 8.  Circadian misalignment in mood disturbances.

Authors:  Alfred J Lewy
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

9.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

10.  Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT.

Authors:  Ingeborg M van Geijlswijk; Kristiaan B van der Heijden; A C G Egberts; Hubert P L M Korzilius; Marcel G Smits
Journal:  Psychopharmacology (Berl)       Date:  2010-07-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.